← Royalty Pharma plc
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | — | — | — | — | $42.8m | $1.1b | $859.0m | $770.9m | |
| Net Income From Continuing Operations | — | — | — | — | $230.1m | $1.7b | $1.3b | $1.3b | |
| Amortization Cash Flow | — | — | — | $23.0m | $5.7m | $0 | $0 | — | |
| Amortization Of Intangibles | — | — | — | $23.0m | $5.7m | $0 | $0 | — | |
| Depreciation | — | — | — | — | — | $0 | $0 | $3.9m | |
| Depreciation Amortization Depletion | — | — | — | — | $5.7m | $0 | $0 | $3.9m | |
| Asset Impairment Charge | — | — | — | $0 | $615.8m | $0 | $0 | — | |
| Distributions from equity method investees | $39.4m | $14.1m | $42.3m | $34.4m | $0 | $43.9m | $23.6m | $105.1m | |
| Investments in equity method investees | ($24.2m) | ($27.0m) | ($40.2m) | ($34.9m) | ($9.9m) | ($12.5m) | ($11.0m) | $0 | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | $9.0m | ($28.9m) | ($29.6m) | ($29.1m) | |
| Cash collections from financial royalty assets | $2.1b | $1.9b | $2.1b | $2.3b | $2.5b | $3.2b | $3.0b | $3.4b | |
| Cash collections from intangible royalty assets | $106.7m | $143.3m | $143.8m | $151.2m | $72.9m | $1.3m | $14.6m | $720k | |
| Other royalty cash collections | $125.2m | $27.4m | $18.3m | $44.1m | $69.9m | $158.8m | $108.8m | $114.0m | |
| Interest received | $24.4m | $20.1m | $7.7m | $3.1m | $25.0m | $71.6m | $46.5m | $34.3m | |
| Development-stage funding payments | — | — | — | — | — | ($52.0m) | ($2.0m) | ($452.0m) | |
| Payments for operating and professional costs | ($72.5m) | ($88.5m) | ($179.7m) | ($184.5m) | ($223.0m) | ($243.0m) | ($236.2m) | ($288.1m) | |
| Payments for Employee EPAs | — | — | — | — | — | $0 | $0 | ($10.9m) | |
| Purchases of equity securities | ($152.8m) | ($79.0m) | ($50.0m) | ($135.1m) | ($87.8m) | $0 | ($62.5m) | ($58.4m) | |
| Proceeds from equity securities | $0 | $0 | $384.8m | $116.0m | $211.2m | $0 | $98.6m | $34.7m | |
| Purchases of available for sale debt securities | $0 | ($125.1m) | $0 | ($70.4m) | ($479.6m) | $0 | ($150.0m) | ($175.0m) | |
| Proceeds from sales and maturities of marketable securities | $0 | $725.1m | $815.4m | $1.6b | $792.3m | $24.4m | $0 | $0 | |
| Acquisitions of financial royalty assets | ($269.6m) | ($1.7b) | ($2.2b) | ($2.2b) | ($1.7b) | ($2.1b) | ($2.5b) | ($1.7b) | |
| Acquisitions of other financial assets | — | — | $0 | $0 | ($21.2m) | $0 | ($18.0m) | $0 | |
| Milestone payments | $0 | ($250.0m) | $0 | ($18.6m) | $0 | ($12.4m) | ($75.0m) | ($271.3m) | |
| Other | — | — | — | $0 | $0 | ($2.0m) | ($9.0m) | ($1.8m) | |
| Distributions to legacy non-controlling interests - Portfolio Receipts | — | — | — | ($479.6m) | ($442.0m) | ($377.0m) | ($362.3m) | ($354.9m) | |
| Distributions to continuing non-controlling interests | ($268.7m) | ($154.1m) | ($544.0m) | ($479.6m) | ($144.1m) | ($119.5m) | ($125.2m) | ($167.5m) | |
| Repurchases of Class A ordinary shares | $0 | ($4.3m) | $0 | $0 | $0 | ($304.8m) | ($229.7m) | ($1.2b) | |
| Contributions from legacy non-controlling interests - R&D | $0 | $0 | $8.5m | $7.3m | $1.1m | $543k | $747k | $220k | |
| Contributions from non-controlling interests - other | $0 | $0 | $59.0m | $36.9m | $6.1m | $6.9m | $4.4m | $5.7m | |
| Cash acquired in connection with purchase of non-controlling interest | — | — | — | $0 | $0 | $5.0m | $0 | $0 | |
| Proceeds from revolving credit facility | — | — | — | $0 | $0 | $350.0m | $0 | $1.3b | |
| Repayment of revolving credit facility | — | — | — | $0 | $0 | ($350.0m) | $0 | ($1.3b) | |
| Beginning Cash Position | — | — | — | — | $1.5b | $1.7b | $477.0m | $929.0m | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | ($944.9m) | ($2.1b) | $361.1m | ($1.2b) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | ($1.0b) | ($2.1b) | ($2.7b) | ($1.6b) | |
| Change In Account Payable | — | — | — | — | $2.3m | $6.2m | ($2.3m) | ($13.9m) | |
| Change In Accrued Expense | — | — | — | — | ($3.5m) | ($2.5m) | $46.4m | $8.9m | |
| Change In Interest Payable | — | — | — | — | ($3.5m) | ($2.5m) | $46.4m | $8.9m | |
| Change In Other Current Assets | — | — | — | — | $38.7m | $3.1m | $13.8m | ($7.4m) | |
| Change In Other Current Liabilities | — | — | — | — | — | $0 | $0 | ($2.4m) | |
| Change In Payable | — | — | — | — | $2.3m | $6.2m | ($2.3m) | ($13.9m) | |
| Change In Payables And Accrued Expense | — | — | — | — | ($1.2m) | $3.8m | $44.1m | ($5.0m) | |
| Change In Receivables | — | — | — | — | ($4.7m) | ($1.5m) | ($4.6m) | ($2.4m) | |
| Change In Working Capital | — | — | — | — | $32.7m | $5.4m | $53.4m | ($17.2m) | |
| Changes In Cash | — | — | — | — | $169.7m | ($1.2b) | $452.0m | ($310.3m) | |
| End Cash Position | — | — | — | — | $1.7b | $477.0m | $929.0m | $618.7m | |
| Financing Cash Flow | — | — | — | — | ($944.9m) | ($2.1b) | $361.1m | ($1.2b) | |
| Free Cash Flow | — | — | — | — | $2.1b | $3.0b | $2.8b | $2.5b | |
| Gain Loss On Investment Securities | — | — | — | — | ($2.2b) | ($2.5b) | ($2.3b) | ($2.3b) | |
| Investing Cash Flow | — | — | — | — | ($1.0b) | ($2.1b) | ($2.7b) | ($1.6b) | |
| Issuance Of Capital Stock | — | — | — | $0 | $0 | — | — | — | |
| Net Business Purchase And Sale | — | — | — | — | ($9.9m) | ($12.5m) | ($11.0m) | ($74.4m) | |
| Operating Gains Losses | — | — | — | — | ($2.2b) | ($2.5b) | ($2.4b) | ($2.3b) | |
| Other Non Cash Items | — | — | — | — | $2.5b | $3.2b | $3.0b | $3.4b | |
| Provisionand Write Offof Assets | — | — | — | — | $904.2m | $560.7m | $732.5m | ($206.8m) | |
| Purchase Of Business | — | — | — | — | ($9.9m) | ($12.5m) | ($11.0m) | ($74.4m) | |
| Repurchase Of Capital Stock | — | — | — | — | $0 | ($304.8m) | ($229.7m) | ($1.2b) | |
| Stock Based Compensation | — | — | — | — | $2.2m | $2.4m | $2.3m | $289.9m | |
| Net cash provided by operating activities | $1.6b | $1.7b | $2.0b | $2.0b | $2.1b | $3.0b | $2.8b | $2.5b | |
| Acquisition of businesses, net of cash acquired | — | — | — | — | — | $0 | $0 | ($74.4m) | |
| Net Investment Purchase And Sale | — | — | — | — | ($1.0b) | ($2.1b) | ($2.6b) | ($1.4b) | |
| Purchase Of Investment | — | — | — | — | ($2.6b) | ($2.1b) | ($2.7b) | ($1.9b) | |
| Sale Of Investment | — | — | — | — | $1.5b | $25.8m | $118.4m | $566.5m | |
| Net Other Investing Changes | — | — | — | ($18.6m) | — | ($14.4m) | ($73.0m) | ($280.3m) | |
| Net cash used in investing activities | $303.4m | ($2.2b) | ($2.8b) | ($1.9b) | ($1.0b) | ($2.1b) | ($2.7b) | ($1.6b) | |
| Proceeds from available for sale debt securities | $750.0m | $150.0m | $3.0m | $62.5m | $542.0m | $1.4m | $19.8m | $21.2m | |
| Proceeds from sales of available for sale debt securities | — | — | — | — | — | $0 | $0 | $510.6m | |
| Proceeds from issuance of long-term debt, net of discount | — | $0 | $11.9b | $1.3b | $0 | $0 | $1.5b | $2.0b | |
| Debt issuance costs and other | ($2.0m) | $0 | ($46.7m) | ($13.0m) | ($1.3m) | ($1.6m) | ($12.6m) | ($16.6m) | |
| Issuance Of Debt | — | — | — | — | $0 | $350.0m | $1.5b | $3.2b | |
| Long Term Debt Issuance | — | — | — | — | $0 | $350.0m | $1.5b | $3.2b | |
| Net Issuance Payments Of Debt | — | — | — | — | $0 | ($1.0b) | $1.5b | $954.5m | |
| Net Long Term Debt Issuance | — | — | — | — | $0 | ($1.0b) | $1.5b | $954.5m | |
| Net Short Term Debt Issuance | — | — | — | $0 | $0 | $0 | — | — | |
| Short Term Debt Issuance | — | — | — | $0 | $0 | $350.0m | — | — | |
| Repayment of long-term debt | — | — | — | $0 | $0 | ($1.0b) | $0 | ($1.0b) | |
| Long Term Debt Payments | — | — | — | — | $0 | ($1.4b) | $0 | ($2.3b) | |
| Repayment Of Debt | — | — | — | — | $0 | ($1.4b) | $0 | ($2.3b) | |
| Short Term Debt Payments | — | — | — | $0 | $0 | ($350.0m) | — | — | |
| Common Stock Issuance | — | — | — | $0 | $0 | — | — | — | |
| Net Common Stock Issuance | — | — | — | — | $0 | ($304.8m) | ($229.7m) | ($1.2b) | |
| Common Stock Payments | — | — | — | — | $0 | ($304.8m) | ($229.7m) | ($1.2b) | |
| Dividends to shareholders | $0 | $0 | ($112.5m) | ($285.2m) | ($333.3m) | ($358.3m) | ($376.5m) | ($378.3m) | |
| Cash Dividends Paid | — | — | — | — | ($333.3m) | ($358.3m) | ($376.5m) | ($378.3m) | |
| Common Stock Dividend Paid | — | — | — | — | ($333.3m) | ($358.3m) | ($376.5m) | ($378.3m) | |
| Dividend Received CFO | — | — | — | — | $39.1m | $18.8m | $13.4m | $13.4m | |
| Dividends Received CFI | — | — | — | — | $0 | $43.9m | $23.6m | $105.1m | |
| Net Other Financing Charges | — | — | — | — | ($611.5m) | ($485.7m) | ($504.0m) | ($534.8m) | |
| Net cash (used in)/provided by financing activities | ($1.4b) | ($1.2b) | $1.5b | $385.1m | ($944.9m) | ($2.1b) | $361.1m | ($1.2b) | |
| Net change in cash and cash equivalents | $542.6m | ($1.7b) | $762.5m | $532.4m | $169.7m | ($1.2b) | $452.0m | ($310.3m) | |
| Cash and cash equivalents, beginning of period | $1.9b | $246.2m | $1.0b | $1.5b | $1.7b | $477.0m | $929.0m | $618.7m | |
| Change In Cash Supplemental As Reported | — | — | — | — | $169.7m | ($1.2b) | $452.0m | ($310.3m) | |
| Interest paid | ($267.7m) | ($255.0m) | ($103.2m) | ($130.4m) | ($170.1m) | ($169.2m) | ($159.6m) | ($276.3m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.